To include your compound in the COVID-19 Resource Center, submit it here.

Arrakis in-licenses RNA-targeted small molecule IP

The University of Pennsylvania granted Arrakis Therapeutics Inc. (Waltham, Mass.) exclusive rights to IP and technology related to

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE